Form 8-K - Current report:
SEC Accession No. 0001104659-24-132255
Filing Date
2024-12-30
Accepted
2024-12-30 07:00:10
Documents
14
Period of Report
2024-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431943d1_8k.htm   iXBRL 8-K 28794
2 EXHIBIT 10.1 tm2431943d1_ex10-1.htm EX-10.1 34286
  Complete submission text file 0001104659-24-132255.txt   248144

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrns-20241223.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20241223_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20241223_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2431943d1_8k_htm.xml XML 3821
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 241586931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)